Mahak Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth 49.91%
- Profit Growth -120.77%
- Ebitda -110.52%
- Net Worth -291.76%
- Total Assets 0.52%
About Mahak Pharma
Mahak Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2015 (Nine years and nine months 16 days old ). Its registered office is in Central Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Kanishka Jain and Rishab Jain serve as directors at the Company.
Company Details
-
Location
Central Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2015PTC279215
-
Company No.
279215
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Apr 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Mahak Pharma Private Limited offer?
Mahak Pharma Private Limited offers a wide range of products and services, including Salon, Spa Kits & Equipments, Steamer & Massager Equipment.
Who are the key members and board of directors at Mahak Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanishka Jain
|
Director | 09-Sep-2017 | Current |
|
Rishab Jain
|
Director | 16-Aug-2022 | Current |
Financial Performance of Mahak Pharma.
Mahak Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.91% increase. The company also saw a substantial fall in profitability, with a 120.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 291.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahak Pharma?
Unlock access to Mahak Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Rishabglobal Industries Private LimitedRishab Jain is a mutual person
-
Jiaana Global LlpKanishka Jain and Rishab Jain are mutual person
-
Mahak (Global) Limited
Kanishka Jain and Rishab Jain are mutual person
-
Rishab Ayurveda Private Limited
Rishab Jain is a mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2024 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Mahak Pharma?
Unlock and access historical data on people associated with Mahak Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahak Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahak Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
